Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production

Journal of Clinical Investigation

Volumn 111, Issue 4, 2003, Pages 463-468

  Fisher, Simon J ^a,b   Kahn, C Ronald ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; INSULIN; NOVOLIN R; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG TOLERANCE; GLUCONEOGENESIS; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; KNOCKOUT MOUSE; LIVER SPECIFIC INSULIN RECEPTOR KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0037324750     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI16426     Document Type: Article

References (38)

1. Ader, M., and Bergman, R.N. 1990. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am. J. Physiol. 245:E1020-E1032.
2. Giacca, A., et al. 1992. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J. Clin. Invest. 90:1769-1777.
3. Mittelman, S.D., Fu, Y.Y., Rebrin, K., Steil, G.M., and Bergman, R.N. 1997. Indirect effect of insulin to suppress endogeneous glucose production is dominant, even with hyperglucoagonemia. J. Clin. Invest. 100:3121-3130.
4. Sindelar, D.K., Balcom, J.H., Chu, C.A., Neal, D.W., and Cherrington, A.D. 1996. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes. 45:1594-1605.
5. Lewis, G.F., Zinman, B., Groenwoud, Y., Vranic, M., and Giacca, A. 1996. Hepatic glucose production is regulated both by direct hepatic and extra hepatic effects of insulin in humans. Diabetes. 45:454-462.
6. Lewis, G.F., Carpentier, A., Vranic, M., and Giacca, A. 1999. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes. 48:570-576.
7. Rebrin, K., Steil, G.M., Getty, L., and Bergman, R.N. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 44:1038-1045.
8. Lewis, G.F., Vranic, M., Harley, P., and Giacca, A. 1997. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes. 46:1111-1119.
9. Sindelar, D., Chu, C., Rohlie, M., Neal, D.W., and Swift, L.L. 1997. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes. 46:187-196.
10. Mittelman, S.D., and Bergman, R.N. 2000. Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. Am. J. Physiol. Endocrinol. Metab. 279:E630-E637.
11. Consoli, A., Nurjhan, N., Capani, F., and Gerich, J. 1989. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes. 38:550-557.
12. Magnusson, I., Rothman, D.L., Katz, L.D., Shulman, R.G., and Shulman, G.I. 1992. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J. Clin. Invest. 90:1323-1327.
13. 13C nuclear magnetic resonance spectroscopy study. J. Clin. Invest. 95:783-787.
14. Boden, G., Chen, X., and Stein, T.P. 2001. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 280:E23-E30.
15. Gupta, N., et al. 1998. Euglycemia acutely restores the direct hepatic effect of insulin on glucose production in depancreatised dogs. Diabetes. 44:A41. (Abstr.)
16. Stevenson, R.W., Williams, P.E., and Cherrington, A.D. 1987. Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog. Diabetologia. 30:782-790.
17. Giacca, A., Fisher, S.J., McCall, R.H., Shi, Z.Q., and Vranic, M. 1997. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon. Endocrinology. 138:999-1007.
18. Lewis, G.F., Vranic, M., and Giacca, A. 1997. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am. J. Physiol. 272:E371-E378.
19. Michael, M.D., et al. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell. 6:87-97.
20. Rizza, R.A., Mandarino, L.J., Genest J., Baker, B.A., and Gerich, J.E. 1985. Production of insulin resistance by hyperinsulinaemia in man. Diabetologia. 28:70-75.
21. Marangou, A.G., et al. 1986. Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes. 35:1383-1389.
22. Radziuk, J., Barron, P., Najm, H., and Davies, J. 1993. The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs. J. Clin. Invest. 92:1713-1721.
23. Bruning, J.C., et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell. 2:559-569.
24. Postic, C., et al. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:305-315.
25. Gerich, J.E., Meyer, C., Woerle, H.J., and Stumvoll, M. 2001. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care. 24:382-391.
26. Moller, N., Rizza, R.A., Ford, G.C., and Nair, K.S. 2001. Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers. Diabetes. 50:747-751.
27. Bevilacqua, S., et al. 1990. Operation of Randle's cycle in patients with NIDDM. Diabetes. 39:383-389.
28. Fanelli, C., et al. 1993. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J. Clin. Invest. 92:1617-1622.
29. Saloranta, C., et al. 1993. Contribution of muscle and liver to glucosefatty acid cycle in humans. Am. J. Physiol. 264:E599-E605.
30. Boden, G., Chen, X., Ruiz, J., White, J.V., and Rossetti, L. 1994. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93:2438-2446.
31. Chu, C.A., et al. 2002. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 282:E402-E411.
32. Boden, G., Chen, X., Capulong, E., and Mozzoli, M. 2001. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes. 50:810-816.
33. Williamson, J.R., Kreisberg, R.A., and Felts, P.W. 1966. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc. Natl. Acad. Sci. USA. 56:247-254.
34. Griffin, M.E., et al. 1999. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 48:1270-1274.
35. Dresner, A., et al. 1999. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103:253-259.
36. Kim, J.K., et al. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. USA. 98:7522-7527.
37. Samuel, V.T., Yu, C., Chen, Y., Zong, H., and Shulman, G.I. 2002. Mechanism of far induced hepatic insulin resistance. Diabetes. SI(Suppl. 2):A68. (Abstr.)
38. Yamatani, K., et al. 1992. Role of FFA-glucose cycle in glucoregulation during exercise in total absence of insulin. Am. J. Physiol. 263:E646-E653.